Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

Wim Kruit; HH van Ojik; VG Brichard; B Escudier; T Dorval; B Dreno; P Patel; N van Baren; MF Avril; S Piperno; A Khammari; M Stas; G Ritter; B Lethe; D Godelaine; F Brasseur; Y (Yong) Zhang; P (Pierre) van der Bruggen; T Boon; Lex Eggermont; M Marchand

doi:10.1002/ijc.21264

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

Wim Kruit
, HH van Ojik
, VG Brichard
, B Escudier
, T Dorval
, B Dreno
, P Patel
, N van Baren
, MF Avril
, S Piperno
, A Khammari
, M Stas
, G Ritter
, B Lethe
, D Godelaine
, F Brasseur
, Y (Yong) Zhang
, P (Pierre) van der Bruggen
, T Boon
, Lex Eggermont

M Marchand

Research output: Contribution to journal › Article › Academic › peer-review

150 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	596-604
Number of pages	9
Journal	International Journal of Cancer
Volume	117
Issue number	4
DOIs	https://doi.org/10.1002/ijc.21264
Publication status	Published - 2005

Research programs

EMC MM-03-47-11
EMC MM-03-86-12

Access to Document

10.1002/ijc.21264

http://hdl.handle.net/1765/70461

Cite this

Kruit, W., van Ojik, HH., Brichard, VG., Escudier, B., Dorval, T., Dreno, B., Patel, P., van Baren, N., Avril, MF., Piperno, S., Khammari, A., Stas, M., Ritter, G., Lethe, B., Godelaine, D., Brasseur, F., Zhang, Y., van der Bruggen, P., Boon, T., ... Marchand, M. (2005). Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma. International Journal of Cancer, 117(4), 596-604. https://doi.org/10.1002/ijc.21264

@article{b969e99e5beb4e0eaa4780635c0033db,

title = "Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma",

author = "Wim Kruit and \{van Ojik\}, HH and VG Brichard and B Escudier and T Dorval and B Dreno and P Patel and \{van Baren\}, N and MF Avril and S Piperno and A Khammari and M Stas and G Ritter and B Lethe and D Godelaine and F Brasseur and Zhang, \{Y (Yong)\} and \{van der Bruggen\}, \{P (Pierre)\} and T Boon and Lex Eggermont and M Marchand",

year = "2005",

doi = "10.1002/ijc.21264",

language = "Undefined/Unknown",

volume = "117",

pages = "596--604",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley \& Sons Inc.",

number = "4",

}

Kruit, W, van Ojik, HH, Brichard, VG, Escudier, B, Dorval, T, Dreno, B, Patel, P, van Baren, N, Avril, MF, Piperno, S, Khammari, A, Stas, M, Ritter, G, Lethe, B, Godelaine, D, Brasseur, F, Zhang, Y, van der Bruggen, P, Boon, T, Eggermont, L & Marchand, M 2005, 'Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma', International Journal of Cancer, vol. 117, no. 4, pp. 596-604. https://doi.org/10.1002/ijc.21264

TY - JOUR

T1 - Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

AU - Kruit, Wim

AU - van Ojik, HH

AU - Brichard, VG

AU - Escudier, B

AU - Dorval, T

AU - Dreno, B

AU - Patel, P

AU - van Baren, N

AU - Avril, MF

AU - Piperno, S

AU - Khammari, A

AU - Stas, M

AU - Ritter, G

AU - Lethe, B

AU - Godelaine, D

AU - Brasseur, F

AU - Zhang, Y (Yong)

AU - van der Bruggen, P (Pierre)

AU - Boon, T

AU - Eggermont, Lex

AU - Marchand, M

PY - 2005

Y1 - 2005

U2 - 10.1002/ijc.21264

DO - 10.1002/ijc.21264

M3 - Article

C2 - 15945101

SN - 0020-7136

VL - 117

SP - 596

EP - 604

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 4

ER -